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• THE AGES OF 5 AND 15 YEARS
• ATAXIA
• HEART DISEASE 
• SPINAL CORD AND PERIPHERAL NERVES DEGENERATE
• CEREBELLUM (AWKWARD, UNSTEADY MOVEMENTS AND IMPAIRED SENSORY 
FUNCTIONS)
Include loss of tendon reflexes, especially in the 
knees and ankles






loss of tendon 
reflexes, 

















loss of vibratory 
and position 























as late as age 
75
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treatments for diabetes, if present
Surgical procedures
Insulin





A Potential New Therapeutic Approach for 
Friedreich Ataxia: Induction of Frataxin
Expression With TALE Proteins
Open
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Study of beta cells and neurons indicate incretin
analogs as potential therapeutics for Friedreich’s ataxia. 
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INCREASE FRATAXIN LEVELS THROUGH DRUG 
TREATMENTS, GENETIC ENGINEERING AND 
PROTEIN DELIVERY SYSTEMS
 The Friedreich’s Ataxia Research Alliance (FARA) 
 http://www.curefa.org/index.php
 http://www.fara.org.au/
